Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cormedix Inc (CRMD)

Cormedix Inc (CRMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 183,606
  • Shares Outstanding, K 23,814
  • Annual Sales, $ 430 K
  • Annual Income, $ -26,830 K
  • 60-Month Beta 2.75
  • Price/Sales 430.31
  • Price/Cash Flow N/A
  • Price/Book 11.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.22
  • Number of Estimates 2
  • High Estimate -0.21
  • Low Estimate -0.22
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +56.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.75 +36.78%
on 06/03/19
8.26 -4.78%
on 06/12/19
+0.88 (+12.52%)
since 05/24/19
3-Month
5.75 +36.78%
on 06/03/19
10.76 -26.91%
on 04/03/19
+0.24 (+3.22%)
since 03/26/19
52-Week
1.05 +649.05%
on 06/29/18
13.70 -42.59%
on 02/13/19
+6.71 (+583.91%)
since 06/26/18

Most Recent Stories

More News
CorMedix Inc. Set to Join the Russell 2000(R) Index

CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,...

CRMD : 7.85 (+1.82%)
CorMedix Inc. to Ring NYSE Closing Bell on Monday, June 10

CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,...

CRMD : 7.85 (+1.82%)
CorMedix Inc. to Present at the 20th Annual B. Riley FBR Institutional Investor Conference

CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,...

CRMD : 7.85 (+1.82%)
CorMedix (CRMD) Reports Q1 Loss, Tops Revenue Estimates

CorMedix (CRMD) delivered earnings and revenue surprises of 24.14% and 173.33%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

CRMD : 7.85 (+1.82%)
CorMedix Inc. Reports First Quarter 2019 Financial Results and Provides Business Update

CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,...

CRMD : 7.85 (+1.82%)
Cormedix Announces Presentation of LOCK-IT-100 Study Results at National Kidney Foundation Spring 2019 Meeting

CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,...

CRMD : 7.85 (+1.82%)
CorMedix Inc. to Report First Quarter 2019 Financial Results and Provide a Corporate Update on May 13

CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,...

CRMD : 7.85 (+1.82%)
CorMedix Announces Online Pre-Clinical Abstract at the Upcoming Annual Meeting of American Society of Clinical Oncology

CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,...

CRMD : 7.85 (+1.82%)
CorMedix Completes Sale of $5.4 Million of NOL Tax Benefits Through New Jersey Economic Development Authority Program

CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,...

CRMD : 7.85 (+1.82%)
CorMedix Notified of Compliance with NYSE American Listing Requirements

BERKELEY HEIGHTS, NJ / ACCESSWIRE / April 11, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

CRMD : 7.85 (+1.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade CRMD with:

Business Summary

CorMedix Inc. is a development-stage pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix's goal is to treat kidney disease by reducing the commonly associated cardiovascular...

See More

Key Turning Points

2nd Resistance Point 8.28
1st Resistance Point 8.00
Last Price 7.85
1st Support Level 7.53
2nd Support Level 7.34

See More

52-Week High 13.70
Fibonacci 61.8% 8.87
Last Price 7.85
Fibonacci 50% 7.38
Fibonacci 38.2% 5.88
52-Week Low 1.05

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar